Evidence map›Paper›PMID 29095089›Full record

ArticlePharmacogenomics

Impact of

Xiaofeng Gao, Huan Wang, Hui Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmacogenomics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Observational
  2. Pharmacogenetic factors affecting β-blocker metabolism and response.Expert opinion on drug metabolism & toxicology · 2020
    Review
  3. Observational
  4. [Effects of CYP2D6Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Xiaofeng GaoFujian Provincial Cardiovascular Disease Institute, Fujian Medical University, Fuzhou, Fujian, P.R. China.
Huan WangFujian Provincial Cardiovascular Disease Institute, Fujian Medical University, Fuzhou, Fujian, P.R. China.
Hui ChenDepartment of Internal Medicine, Fujian Provincal Cardiovascular Disease Institute, Provincial Clinical College of Fujian Medical University, 134 East Street, Fuzhou, Fujian 350001, P.R. China.
Fujian Medical University · CN

Funding

National Natural Science Foundation of China 81373838
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cytochrome P-450 CYP2D6Heart RateMetoprololReceptors, Adrenergic, beta-1Adrenergic beta-1 Receptor AntagonistsAgedFemaleGene FrequencyGenotypeHumansMaleMiddle AgedPolymorphism, GeneticPolymorphism, Single NucleotideADRB1 protein, humanAdrenergic beta-1 Receptor AntagonistsCytochrome P-450 CYP2D6MetoprololReceptors, Adrenergic, beta-1heart ratemetoprolol succinate sustained-release tabletspharmacogenomics of metoprololpost-PCItarget heart rate

Identifiers

PMID29095089
PMCPMC13374743
OpenAlexW2766003077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.